Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous morphine effects on sleep-disordered breathing in moderate obstructive sleep apnoea
2014-001950-41Phase 4Terminated
- Sponsor
- Royal Papworth Hospital
- Start
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of morphine in obstructive sleep apnea hypopnea syndrome (OSAHS), sponsored by Royal Papworth Hospital. Primary endpoint: Change in apnoea-hypopnoea index. Started Jun 2015; status: terminated.
02
Drugs
morphine
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on 2014-001950-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001950-41.